Bristol’s Next Cost Savings Target: Working Capital

Goal is to strengthen cash flow by $750 million to $1 billion through improvements in working capital by 2011.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet